BChE/HDAC6-IN-2

CAT:
804-HY-149418
Size:
Inquire
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
BChE/HDAC6-IN-2 - image 1

BChE/HDAC6-IN-2

  • UNSPSC Description:

    BChE/HDAC6-IN-2 (compound 29a) is a dual inhibitor of BChE and HDAC6 with IC50s of 1.8 nM and 71.0 nM, respectively. BChE/HDAC6-IN-2 has prominently neuroprotective effects and reactive oxygen species (ROS) scavenging activity. BChE/HDAC6-IN-2 is also an effective chelator of metal ion (Fe2+ and Cu2+). BChE/HDAC6-IN-2 inhibits phosphorylation of tau, and exhibits moderate immunomodulatory effect.
  • Target Antigen:

    Cholinesterase (ChE); HDAC; Tau Protein
  • Type:

    Reference compound
  • Related Pathways:

    Cell Cycle/DNA Damage;Epigenetics;Neuronal Signaling
  • Applications:

    Neuroscience-Neurodegeneration
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/bche-hdac6-in-2.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C(NCC1=CC=CC=C1CN(CC)CC)C2=CC(NC(C3=CC(C(NO)=O)=CC=C3)=O)=CC=C2
  • Molecular Weight:

    474.55
  • References & Citations:

    [1]Wang L, Sun T, Wang Z, Liu H, Qiu W, Tang X, Guo H, Yang P, Chen Y, Sun H. Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer's Disease. ACS Chem Neurosci. 2023 Sep 6;14(17):3226-3248.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported
  • CAS Number:

    2925457-33-4